Clinical Trial Update: Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

A randomized Phase 4 trial comparing Abciximab plus heparin versus Bivalirudin for acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• Abciximab (abciximab)
• Bivalirudin (bivalirudin)
• Heparin (unfractionated heparin)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Myocardial Infarction, Coronary Disease | Phase 4 | Status: COMPLETED